Oxiconazole


Full Prescribing Info
Dosage/Direction for Use

Topical/Cutaneous
Tinea corporis
Adult: As 1% cream or lotion: Apply to affected and immediately surrounding areas 1-2 times daily. Duration of treatment: 2 wk for tinea corporis and tinea cruris or 1 mth for tinea pedis.

Topical/Cutaneous

Tinea cruris
Adult: As 1% cream or lotion: Apply to affected and immediately surrounding areas 1-2 times daily. Duration of treatment: 2 wk for tinea corporis and tinea cruris or 1 mth for tinea pedis.

Topical/Cutaneous

Tinea pedis
Adult: As 1% cream or lotion: Apply to affected and immediately surrounding areas 1-2 times daily. Duration of treatment: 2 wk for tinea corporis and tinea cruris or 1 mth for tinea pedis.

Topical/Cutaneous

Pityriasis versicolor
Adult: As 1% cream: Apply to affected areas once daily for 2 wk.
Contraindications
Hypersensitivity.
Special Precautions
Pregnancy and lactation. Patient Counselling Avoid contact w/ eyes or vagina.
Adverse Reactions
Pruritus, burning, irritation, stinging, erythema, rash, folliculitis, papules, nodules, maceration, fissuring, scaling, tingling, pain, dyshidrotic eczema, contact dermatitis.
Action
Oxiconazole, a synthetic azole antifungal, is usually fungistatic but may be fungicidal in high concentrations. It exerts its antifungal activity by interfering w/ ergosterol synthesis and altering cellular membranes. It also has some antibacterial activity against aerobic gm+ve organisms.
Absorption: Absorbed in each dermis layer. Very low systemic absorption.
Distribution: To each dermis layer.
Excretion: Via urine (<0.3%).
Storage
Topical/Cutaneous: Store between 15-30°C.
ATC Classification
D01AC11 - oxiconazole ; Belongs to the class of imidazole and triazole derivatives. Used in the topical treatment of fungal infection.
G01AF17 - oxiconazole ; Belongs to the class of imidazole derivative antiinfectives. Used in the treatment of gynecological infections.
Disclaimer: This information is independently developed by CIMS based on oxiconazole from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in